Colorectal multidisciplinary meeting audit to determine patient benefit

Fernando, Chris; Frizelle, Frank; Wakeman, Chris; Frampton, Chris; Robinson, Bridget A.

doi:10.1111/ans.13366

Cited by 16 publications

(23 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…MDT has proven to be effective in the treatment of breast cancer, oral cancer, and prostate cancer [ 9 – 11 ]. In recent years, MDT has become an increasingly popular form of diagnosis and treatment in colorectal cancer [ 12 , 13 ]. The MDT of colorectal cancer is composed of experts in multiple fields including surgery, oncology, radiology, pathology, and other related disciplines [ 14 , 15 ].…”

Section: Introductionmentioning

confidence: 99%

Improved Overall Survival of Colorectal Cancer under Multidisciplinary Team: A Meta‐Analysis

Peng

Cheng

2021

BioMed Research International

View full text Add to dashboard Cite

Purpose. The purpose of the current meta-analysis was to evaluate whether multidisciplinary team improved overall survival of colorectal cancer. Methods. PubMed, EMBASE, and Cochrane Library database were searched from inception to October 25, 2020. The hazard ratio (HR) and 95% confidence (CI) of overall survival (OS) were calculated. Results. A total of 11 studies with 30814 patients were included in this meta-analysis. After pooling the HRs, the MDT group was associated with better OS compared with the non-MDT group ( HR = 0.81 , 95% CI 0.69-0.94, p = 0.005 ). In subgroup analysis of stage IV colorectal cancer, the MDT group was associated with better OS as well ( HR = 0.73 , 95% CI 0.59-0.90, p = 0.004 ). However, in terms of postoperative mortality, no significant difference was found between MDT and non-MDT groups ( OR = 0.84 , 95% CI 0.44-1.61, p = 0.60 ). Conclusion. MDT could improve OS of colorectal cancer patients.

show abstract

Section: Introductionmentioning

confidence: 99%

Improved Overall Survival of Colorectal Cancer under Multidisciplinary Team: A Meta‐Analysis

Peng

Cheng

2021

BioMed Research International

View full text Add to dashboard Cite

show abstract

“…With improved understanding of the disease along with development of medical technology, there is constant improvement and diversification of diagnosis and treatment options for CRC [2,3]. Although some accurate and effective therapeutic regimens are available for early stage CRC [4], there are no definitive or unified treatment plans for CRC with lymph node, local, or distant metastasis [2,3]. In patients with advanced CRC, clinicians are often unable to accurately judge patient condition upon diagnosis because of the complexity of the disease.…”

Section: Introductionmentioning

confidence: 99%

The Effect of Multidisciplinary Team Discussion Intervention on the Prognosis of Advanced Colorectal Cancer

Zhang

Wei

et al. 2021

J. Cancer

View full text Add to dashboard Cite

“…This combination of lack of experience treating patients with peritoneal malignancy and underutilization of a tumor board discussion is likely to significantly influence therapeutic management decisions. Several studies have evaluated the influence of multidisciplinary tumor boards in the management of patients with colorectal cancer, including accuracy of diagnosis and staging, frequency of changes to the individual physician’s initial management plan, and adherence to tumor board recommendations [13, 14, 15]. A recent systematic review of studies that focused on the role and impact of multidisciplinary tumor boards in a variety of gastrointestinal cancers found that a majority of included studies showed that the treatment plan was altered in 23.0–41.7 % of evaluated cases [16].…”

Section: Discussionmentioning

confidence: 99%

Practice patterns, attitudes, and knowledge among physicians regarding cytoreductive surgery and HIPEC for patients with peritoneal metastases

Bernaiche

Emery

Bijelić

2018

Pleura and Peritoneum

View full text Add to dashboard Cite

BackgroundCytoreductive surgery (CRS) and heated intraperitoneal chemotherapy (HIPEC) is a treatment option for patients with peritoneal metastases shown to provide improved overall survival for appropriately selected patients. However, the availability and utilization of this treatment remains limited. The aim of this survey-based study was to evaluate factors influencing physician treatment choices for peritoneal metastases.MethodsSurveys were mailed to medical oncologists and surgeons in Virginia, Maryland, and Washington, D.C. Survey questions evaluated access to HIPEC centers, prior experience with referral to HIPEC centers, opinions regarding efficacy, and knowledge regarding outcomes of CRS and HIPEC.ResultsSurveys were mailed to 2279 physicians; 116 eligible surveys were returned. Seventy-five percent of respondents would consider referral to a HIPEC center for appendiceal peritoneal metastasis, while only 50% would consider it for colon cancer and peritoneal mesothelioma. The most common reason for never referring a patient to a HIPEC center was lack of access to a HIPEC specialist (47%) followed by perceived lack of evidence for the treatment modality (31%). Five-year survival after CRS and HIPEC was underestimated while 30-day mortality was overestimated by more than half of respondents.ConclusionsReferral to HIPEC centers is underutilized among community physicians in practice. Limited access to HIPEC experts is the most common cause for lack of referral, followed by a perception of insufficient evidence for this treatment approach. Lack of familiarity with data regarding outcomes impacts referral patterns and treatment choices. Possible actions to increase awareness and appropriate utilization of CRS and HIPEC are suggested.

show abstract

Colorectal multidisciplinary meeting audit to determine patient benefit

Abstract: Discussion in the MDM influenced management, but was unlikely to change management for AJCC stage I/II colon cancer, who could be spared mandatory review in the MDM and be discussed selectively as treating clinicians decide.

Cited by 16 publications

References 8 publications

Improved Overall Survival of Colorectal Cancer under Multidisciplinary Team: A Meta‐Analysis

Improved Overall Survival of Colorectal Cancer under Multidisciplinary Team: A Meta‐Analysis

The Effect of Multidisciplinary Team Discussion Intervention on the Prognosis of Advanced Colorectal Cancer

Practice patterns, attitudes, and knowledge among physicians regarding cytoreductive surgery and HIPEC for patients with peritoneal metastases

Contact Info

Product

Resources

About